This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Clinical and Laboratory Features of 82 Patients Seen in Private Practice

Eva af Ekenstam, MD; Jeffrey P. Callen, MD

Arch Dermatol. 1984;120(4):484-489.

Abstract
• Eighty-two patients, with pathologically confirmed cutaneous leukocytoclastic vasculitis (LV), were seen in private dermatology offices. An analysis of the group was made to determine the relationship of cutaneous to systemic disease, the incidence and importance of laboratory abnormalities, and the prognosis of patients with cutaneous LV and to compare these results with previously published data derived from medical centers. Systemic disease occurred in 42 patients, but was transient and mild in most. Two patients died as a result of systemic vasculitis. The morphologic type of skin lesions most commonly found were palpable purpura (51 patients), urticarial-like lesions (17 patients), ulcers (eight patients), erythematous plaques (five patients), and/or nodules (five patients). Possible causative agents could be identified in 38 patients and included drugs (eight patients), infections (eight patients), or collagen vascular disease (17 patients). The course of the disorder was acute in 46 cases, chronic in 24, and recurrent in 12. The patients described herein fared better and had less significant systemic disease than those described in studies from medical centers. The data support the usual benign course of cutaneous LV as seen by practitioners despite frequent systemic symptoms or findings.

(Arch Dermatol 1984;120:484-489)

Author Affiliations
From the Division of Dermatology, the University of Louisville School of Medicine.

Footnotes
Accepted for publication April 6, 1983.

Reprint requests to 554 Medical Towers S, Louisville, KY 40202 (Dr Callen).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Leucocytoclastic vasculitic neuropathy diagnosed by biopsy of normal appearing skin
Yamanaka et al.
J. Neurol. Neurosurg. Psychiatry 2006;77:706-707.
FULL TEXT  

Tissue eosinophilia as an indicator of drug-induced cutaneous small-vessel vasculitis.
Bahrami et al.
Arch Dermatol 2006;142:155-161.
ABSTRACT | FULL TEXT  

Prognostic Factors in Leukocytoclastic Vasculitis: What Is the Role of Antineutrophil Cytoplasmic Antibody?
Papi et al.
Arch Dermatol 1999;135:714-715.
FULL TEXT  

Prognostic Factors in Leukocytoclastic Vasculitis: A Clinicopathologic Study of 160 Patients
Sais et al.
Arch Dermatol 1998;134:309-315.
ABSTRACT | FULL TEXT  

Cutaneous Vasculitis: What Have We Learned in the Past 20 Years?
Callen
Arch Dermatol 1998;134:355-357.
FULL TEXT  

Small-Vessel Vasculitis
Jennette and Falk
NEJM 1997;337:1512-1523.
FULL TEXT  

Adhesion Molecule Expression and Endothelial Cell Activation in Cutaneous Leukocytoclastic Vasculitis: An Immunohistologic and Clinical Study in 42 Patients
Sais et al.
Arch Dermatol 1997;133:443-450.
ABSTRACT  

Colchicine in the Treatment of Cutaneous Leukocytoclastic Vasculitis: Results of a Prospective, Randomized Controlled Trial
Sais et al.
Arch Dermatol 1995;131:1399-1402.
ABSTRACT  

Severe Adverse Cutaneous Reactions to Drugs
Roujeau and Stern
NEJM 1994;331:1272-1285.
FULL TEXT  

Azathioprine: An Effective, Corticosteroid-Sparing Therapy for Patients With Recalcitrant Cutaneous Lupus Erythematosus or With Recalcitrant Cutaneous Leukocytoclastic Vasculitis
Callen et al.
Arch Dermatol 1991;127:515-522.
ABSTRACT  

Cutaneous Leukocytoclastic Vasculitis: Serial Histopathologic Evaluation Demonstrates the Dynamic Nature of the Infiltrate
Zax et al.
Arch Dermatol 1990;126:69-72.
ABSTRACT  

Cutaneous Leukocytoclastic Vasculitis With Hyperglobulinemia and Splenomegaly: A Variant of Hyperglobulinemic Purpura of Waldenstrom
Hudson and Callen
Arch Dermatol 1984;120:1224-1226.
ABSTRACT